News

If you're interested in Newro news, you should

Sign Up for our Newsletter

Every few months we let you know what's been going on at the Newro Foundation. If you're interested, fill out the form below.





Brisbane Sing's puts on an amazing show to raise funds for the Newro Foundation!

Published: Aug 8
Media Release 8 August 2017 Brisbane Sings turns QPAC into an orange Latin party to support The Newro Foundation!  Brisbane Sings is a community event featuring choirs and singing groups from all over the city … Read More »

Team Hannam completes the Gold Coast marathon!

Published: Jul 28
Media Release 28 July 2017 Bringing hope to brain cancer patients!  Craig Hannam and his team have brought hope to brain cancer patients by completing the Gold Coast marathon on Sunday, 2 July 2017. Craig Hannam is an inspirational member of the Newro Foundation, dedi… Read More »

Shorne's Walk for Brain Cancer

Published: Jul 29
Media Release 29 July 2016 800 kilometre walk to Brisbane to find a cure Every year over 1400 cases of malignant brain cancers are diagnosed in Australia and after watching his mate Garry Lawton pass f… Read More »

World-first GBM clinical trial

Published: Sep 24
Media Release  Hope for brain cancer patients with world-first clinical trial in Brisbane  A world-first immunotherapy treatment has offered hop… Read More »

Shorne's Walk for Brain Cancer

Published: Aug 24
Congratulations to Shorne Sanders who completed his epic 800 kilometre trek from Rockhampton to Brisbane on 19 August. Walking in memory of his friend Garry Lawton and also his mother, Shorne began his walk on 1 August to raise money for brain cancer research and raise awareness for the diseas… Read More »

Tumor Paint BLZ-100

Published: Jul 22
The Newro Foundation is currently enrolling patients in a clinical study of Tumor Paint BLZ-100, an investigational intra-operative imaging agent for cancer. Tumor Paint, BLZ-100 is being developed by Blaze Bioscience, the Tumor Paint Company® in Seattle, Washington, U.S. The study is actively recruiting adult patients with glioma undergoin… Read More »